A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Yiqun Zhang(Tongji University), Chad J. Creighton(Baylor College of Medicine), Alexei Protopopov, Raju Kucherlapati(Brigham and Women's Hospital), Harshad S. Mahadeshwar(The University of Texas MD Anderson Cancer Center), Melanie H. Kucherlapati(Brigham and Women's Hospital), Christopher A. Bristow(The University of Texas MD Anderson Cancer Center), Jonathan G. Seidman(Harvard University), Peter J. Park(Harvard University), Lixing Yang(University of California San Diego), Xingzhi Song(The University of Texas MD Anderson Cancer Center), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Angeliki Pantazi(Harvard University), Andrew K. Godwin(The University of Melbourne), Thomas F. Westbrook(Baylor College of Medicine), Xiaojia Ren(Harvard University), Toni K. Choueiri(Harvard University), Han Liang(The University of Texas MD Anderson Cancer Center), Yuexin Liu(The University of Texas MD Anderson Cancer Center), Rehan Akbani(The University of Texas MD Anderson Cancer Center), Yiu Huen Tsang(Oregon Health & Science University), Michael Ittmann(Baylor College of Medicine), Elizabeth P. Henske(Brigham and Women's Hospital), Lovelace J. Luquette(Brigham and Women's Hospital), Ruibin Xi(Peking University), Patrick Kwok‐Shing Ng(The University of Texas MD Anderson Cancer Center), Angela Hadjipanayis(Sanofi (United States)), Eunjung Lee(University of Southern California), Jianhua Zhang(XinHua Hospital), David J. Kwiatkowski(Brigham and Women's Hospital), Fengju Chen(Baylor College of Medicine), Guillermo de Velasco(Dana-Farber Cancer Institute), Semin Lee(Ulsan National Institute of Science and Technology), Lynda Chin(American Productivity and Quality Center), Carl Simon Shelley(University of Wisconsin–Madison), Carter Van Waes(National Institute on Deafness and Other Communication Disorders), Jiabin Tang(Cornell University), Kenneth L. Scott(Dana-Farber Cancer Institute), Huandong Sun(The University of Texas MD Anderson Cancer Center), Sahil Seth(The University of Texas MD Anderson Cancer Center), Kang Jin Jeong(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 656
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k